CORTI, CHIARA
CORTI, CHIARA
Universita' degli Studi di MILANO
A set of easy and stringent criteria to identify immune-related adverse events (IrAE Scoring System, ISS) improves correlation with outcome in a phase 1-2 trial population
2022 L. Mazzarella, F. Giugliano, E. Nicolo', E. Crimini, J. Uliano, C. Corti, P. D'Amico, P. Aliaga, C. Valenza, M. Repetto, G. Antonarelli, L. Ascione, G. Vivanet, P. Giachetti, I. Minchella, C. Belli, A. Esposito, M. Locatelli, C. Criscitiello, G. Curigliano
Adjuvant treatment of early male breast cancer
2020 C. Corti, E. Crimini, C. Criscitiello, D. Trapani, G. Curigliano
Antibody–drug conjugates for the treatment of breast cancer
2021 C. Corti, F. Giugliano, E. Nicolo, L. Ascione, G. Curigliano
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies
2022 P. Tarantino, R. Carmagnani Pestana, C. Corti, S. Modi, A. Bardia, S.M. Tolaney, J. Cortes, J.-. Soria, G. Curigliano
Artificial intelligence as an adjunct tool for breast oncologists – are we there yet?
2023 S.I. I., M. Saad Menezes, C. Corti, A. Tan, I. Abuali, S. Tolaney
Artificial intelligence for prediction of treatment outcomes in breast cancer: Systematic review of design, reporting standards, and bias
2022 C. Corti, M. Cobanaj, F. Marian, E.C. Dee, M.R. Lloyd, S. Marcu, A. Dombrovschi, G.P. Biondetti, F. Batalini, L.A. Celi, G. Curigliano
Artificial intelligence in cancer research and precision medicine: Applications, limitations and priorities to drive transformation in the delivery of equitable and unbiased care
2023 C. Corti, M. Cobanaj, E.C. Dee, C. Criscitiello, S.M. Tolaney, L.A. Celi, G. Curigliano
Association between the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and efficacy of CDK 4/6 inhibitors in advanced breast cancer: The observational multicenter Italian PALMARES study
2020 E. Zattarin, C. Fabbroni, F. Ligorio, A. Marra, C. Corti, O. Bernocchi, M. Sirico, D. Generali, G. Curigliano, G. Bianchi, G. Capri, L. Rivoltini, F. De Braud, C. Vernieri
Auto-immune toxiity of Sars-Cov2 vaccine in patients with thymic epithelial tumours: a prospective analysis from the tyme net
2021 F. Giugliano, C. Corti, F. Conforti, P. Queirolo, E. Pennacchioli, C. Catania, L. Pala, G. Curigliano, T. De Pas
Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial
2022 F. Conforti, P.A. Zucali, L. Pala, C. Catania, V. Bagnardi, I. Sala, P. Della Vigna, M. Perrino, P. Zagami, C. Corti, S. Stucchi, M. Barberis, E. Guerini-Rocco, B. Di Venosa, F. De Vincenzo, N. Cordua, A. Santoro, G. Giaccone, T.M. De Pas
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents
2023 E. Nicolò, P. Tarantino, O. D'Ecclesiis, G. Antonarelli, L. Boscolo Bielo, A. Marra, S. Gandini, E. Crimini, F. Giugliano, P. Zagami, C. Corti, D. Trapani, S. Morganti, C. Criscitiello, M. Locatelli, C. Belli, A. Esposito, I. Minchella, M. Cristofanilli, S.M. Tolaney, G. Curigliano
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents
2022 P. Tarantino, O. D'Ecclesiis, E. Nicolò, G. Antonarelli, L. Boscolo Bielo, A. Marra, S. Gandini, E. Crimini, F. Giugliano, P. Zagami, C. Corti, D. Trapani, S. Morganti, C. Criscitiello, M.A. Locatelli, C. Belli, A. Esposito, I. Minchella, S.M. Tolaney, G. Curigliano
Benefit of adjuvant chemotherapy in patients with lobular breast cancer : A systematic review of the literature and metanalysis
2021 D. Trapani, S. Gandini, C. Corti, E. Crimini, F. Bellerba, I. Minchella, C. Criscitiello, P. Tarantino, G. Curigliano
Breast Cancer Genetics: Diagnostics and Treatment
2022 C. Criscitiello, C. Corti
Broadening the scope of artificial intelligence in oncology
2023 R. Ravella, E.C. Dee, C. Corti, L.A. Celi, P. Iyengar
Building up a high-throughput screening platform to assess the heterogeneity of HER2 gene amplification in breast cancers
2017 G. Ercoli, G. Lopez, C. Ciapponi, C. Corti, L. Despini, D. Gambini, L. Runza, C. Blundo, A. Sciarra, N. Fusco
Bystander effect of antibody-drug conjugates: fact or fiction?
2022 F. Giugliano, C. Corti, P. Tarantino, F. Michelini, G. Curigliano
Cancer immunotherapy: tools and strategies to unmask a master of disguise
2020 C. Criscitiello, C. Corti
CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress
2022 C. Corti, K. Venetis, E. Sajjadi, L. Zattoni, G. Curigliano, N. Fusco
Characterization of low HER2 expressions in de-novo metastatic breast cancer
2021 P. Tarantino, E. Nicolo, P. Zagami, F. Giugliano, P. Aliaga, E. Crimini, C. Corti, J. Uliano, S. Morganti, L. Mazzarella, C. Criscitiello, A. Esposito, G. Curigliano